We worked at triple speed on vaccine patent strategy to help the world, says BioNTech IP chief
“You could go through a practice of 30 years, never experiencing what we have just been through in a year,” says Julie Anne Gillespie in exclusive interview alongside colleague James Ryan
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.